Literature DB >> 7071347

Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.

J F Bonneville, D Poulignot, F Cattin, M Couturier, E Mollet, J L Dietemann.   

Abstract

A group of 17 strictly intrasellar prolactin-secreting pituitary adenomas between 2 and 9 mm in size was examined by computed tomography before and after bromocriptine therapy of 3 months to 1 year duration. These findings were compared with clinical and biological data. Bromocriptine therapy was effective clinically and biologically in 14 of the 17 cases. Of the 15 intrasellar adenomas in nonpregnant patients treated with bromocriptine, six disappeared completely with normalization of the pituitary appearance, five decreased approximately 50% in volume (three showed an increase in density, two a decrease), and four remained unchanged in size (two showed increased density, two showed very low densities).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7071347     DOI: 10.1148/radiology.143.2.7071347

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  4 in total

Review 1.  Medical management of prolactin-secreting pituitary adenomas.

Authors:  Mark E Molitch
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

2.  Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells.

Authors:  R Maggio; M Armogida; M Scarselli; F Salvadori; B Longoni; C Pardini; A Chiarenza; S Chiacchio; F Vaglini; R Bernardini; A Colzi; G U Corsini
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

Review 3.  Diagnosis and management of prolactinomas.

Authors:  J R Dollar; R E Blackwell
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

4.  CT follow-up of microprolactinomas during bromocriptine-induced pregnancy.

Authors:  J L Dietemann; C Portha; F Cattin; E Mollet; J F Bonneville
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.